TRON-Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz is biopharmaceutical research organization that pursues new diagnostics and drugs for the treatment of cancer and other severe diseases with high medical need. A focus of TRON is the development of novel platforms for individualized therapies and biomarkers, translating basic research into drug applications. TRON partners with academic institutions, biotech companies and the pharmaceutical industry, executing research with leading-edge technologies and supporting the development of innovative drugs to promote human health.
Mainz, September 30, 2014 – On October 2, Dr. Javad Aman, will give a guest lecture on the clinical development of a vaccine for Ebola. The 1 p.m. lecture at Building 708, at University Medical Center Mainz takes place as part of the TRON Seminar Series in Translational Oncology. Dr. Aman is a molecular immunologist whose research has resulted in the development of a vaccine for Ebola and Marburg viruses, now in late pre-clinical development.
Mainz, Germany, September 23, 2014 – A new review article by TRON director Ugur Sahin provides a comprehensive overview of the current state of mRNA-based drug technologies and their applications, and discusses the key challenges and opportunities in developing these into a new class of drugs.
The September 4 seminar “New preclinical test systems for an improved analysis of monoclonal antibody function" with Prof. Dr. Ulrich Kalinke Executive Director of TWINCORE, Centre for Experimental and Clinical Infection Research, has been cancelled.
Mainz, August 20, 2014 - "Personalized therapies for lung cancer treatment: a paradigm shift in systematical cancer therapy" with Prof. Dr. med. Jürgen Wolf
Center for Integrated Oncology at the University Hospital Cologne and
Prof. Dr. med. Reinhard Büttner
University of Cologne/ Targos GmbH
Mainz, July 10, 2014 - "Assessment of proliferative activity in breast cancer as a basis for individualized treatment decisions" with Prof. Hans-Anton Lehr – Institute of Pathology, Medizin Campus Bodensee, Friedrichshafen